Таргетное формирование микробиоты младенцев на искусственном вскармливании: современные возможности
https://doi.org/10.15690/vsp.v20i6.2354
Аннотация
В обзоре приводится анализ последних публикаций, посвященных расшифровке с помощью современных исследовательских технологий биологической значимости микробиома младенца. Оценены связи количественных и качественных характеристик микробиоты кишечника с отсроченными нарушениями здоровья. Рассмотрены различные концепции происхождения микробиома новорожденного, сроков и этапов бактериальной колонизации желудочно-кишечного тракта. Представлены данные о роли способа родоразрешения в формировании микробиоты младенца, в том числе значимость контаминации материнской вагинальной флорой, в составе которой онтогенетическая приоритетность принадлежит представителям рода лактобацилл. Установлено, что Lactobacillus fermentum выполняет роль стартовой микрофлоры, обеспечивающей условия для последующей успешной колонизации кишечника ребенка облигатными симбионтами. Подтверждена значимость грудного вскармливания в адекватном становлении микро-биоты. При вынужденном искусственном вскармливании целесообразно обогащение детских молочных смесей компонентами, способствующими селекции симбиотической микрофлоры, в том числе длинноцепочечными полиненасыщенными жирными кислотами, пребиотиками — олигосахаридами и пробиотиками направленного действия. Инновационная смесь, созданная на основе концепции синбиотик/комбиотик, сможет частично компенсировать нарушение формирования микробиоты младенца при вынужденном искусственном вскармливании.
Ключевые слова
Об авторах
И. А. БеляеваРоссия
Беляева Ирина Анатольевна, доктор медицинских наук, профессор РАН, профессор кафедры факультетской педиатрии педиатрического факультета РНИМУ им. Н.И. Пирогова, главный научный сотрудник НИИ педиатрии и охраны здоровья детей ЦКБ РАН, врач-неонатолог высшей квалификационной категории Морозовской детской городской клинической больницы
119333, Москва, ул. Фотиевой, д. 10, к. 1
Раскрытие интересов:
Чтение лекций для компаний АО «ПРОГРЕСС» / «МЕДЕЛА» / «АКРИХИН» / «НЕСТЛЕ» / «HiPP Russ» LLC
Л. С. Намазова-Баранова
Россия
Москва
Раскрытие интересов:
Получение исследовательских грантов от фармацевтических компаний «Пьер Фабр», Genzyme Europe B.V., ООО «АстраЗенека Фармасьютикалз», Gilead / PRA «Фармасьютикал Рисерч Ассошиэйтс СиАйЭс», Teva Branded Pharmaceutical Products R&D, Inc / ООО «ППД Девелопмент (Смоленск)», «Сталлержен С. А.» / «Квинтайлс ГезмбХ» (Австрия), АО «Санофи-авентис груп», ООО «Бионорика», ООО «Нутриция»
Е. П. Бомбардирова
Россия
Москва
Раскрытие интересов:
Автор статьи подтвердил отсутствие конфликта интересов, о котором необходимо сообщить
Т. В. Турти
Россия
Москва
Раскрытие интересов:
Чтение лекций для компаний АО «ПРОГРЕСС» / «АКРИХИН»
П. Е. Садчиков
Россия
Москва
Раскрытие интересов:
Автор статьи подтвердил отсутствие конфликта интересов, о котором необходимо сообщить
Список литературы
1. Milani C, Duranti S, Bottacini F, et al. The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota. Microbiol Mol Biol Rev. 2017;81(4):e00036-17. doi: 10.1128/MMBR.00036-17
2. Sommer F, Backhed F. The gut microbiota — masters of host development and physiology. Nat Rev Microbiol. 2013;11(4): 227–238. doi: 10.1038/nrmicro2974
3. Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016;14(8):e1002533. doi: 10.1371/journal.pbio.1002533
4. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59–65. doi: 10.1038/nature08821
5. Manor O, Dai CL, Kornilov SA, et al. Health and disease markers correlate with gut microbiome composition across thousands of people. Nat Commun. 2020;11(1):5206. doi: 10.1038/s41467-020-18871-1
6. DeGruttola AK, Low D, Mizoguchi A, et al. Current understanding of dysbiosis in disease in human and animal models. Inflamm Bowel Dis. 2016;22(5):1137–1150. doi: 10.1097/MIB.0000000000000750
7. Yang T, Santisteban MM, Rodriguez V, et al. Gut dysbiosis is linked to hypertension. Hypertension. 2015;65(6):1331–1340. doi: 10.1161/HYPERTENSIONAHA.115.05315
8. Battson ML, Lee DM, Jarrell DK, et al. Suppression of gut dysbiosis reverses Western diet-induced vascular dysfunction. Am J Physiol Endocrinol Metab. 2018;314(5):E468–E477. doi: 10.1152/ajpendo.00187.2017
9. Heintz-Buschart A, Wilmes P. Human Gut Microbiome: Function Matters. Trends Microbiol. 2018;26(7):563–574. doi: 10.1016/j.tim.2017.11.002
10. Cenit MC, Sanz Y, Codoñer-Franch P. Influence of gut microbiota on neuropsychiatric disorders. World J Gastroenterol. 2017; 23(30):5486–5498. doi: 10.3748/wjg.v23.i30.5486
11. Indiani CMDSP, Rizzardi KF, Castelo PM, et al. Childhood Obesity and Firmicutes/Bacteroidetes Ratio in the Gut Microbiota: A Systematic Review. Child Obes. 2018;14(8):501–509. doi: 10.1089/chi.2018.0040
12. Ley RE, Backhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA. 2005;102(31):11070–11075. doi: 10.1073/pnas.0504978102
13. Kalliomaki M, Collado MC, Salminen S, et al. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr. 2008;87(3):534–538. doi: 10.1093/ajcn/87.3.534
14. Kalliomaki M, Kirjavainen P, Eerola E, et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol. 2001;107(1):129–134. doi: 10.1067/mai.2001.111237
15. Fujimura KE, Sitarik AR, Havstad S, et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat Med. 2016;22(10):1187–1191. doi: 10.1038/nm.4176
16. Permall DL, Pasha AB, Chen X-Q, Lu H-Y. The lung microbiome in neonates. Turk J Pediatr. 2019;61(6):821–830. doi: 10.24953/turkjped.2019.06.001
17. Turroni F, Milani C, Duranti S, et al. The infant gut microbiome as a microbial organ influencing host well-being. Ital J Pediatr. 2020;46(1):16. doi: 10.1186/s13052-020-0781-0
18. Izaskun GM, Alcantara C, Selma-Royo M, et al. MAMI: a birth cohort focused on maternalinfant microbiota during early life. BMC Pediatr. 2019;19(1):140. doi: 10.1186/s12887-019-1502-y
19. Jimenez E, Marin ML, Martin R, et al. Is meconium from healthy newborns actually sterile? Res Microbiol. 2008;159(3):187–193. doi: 10.1016/j.resmic.2007.12.007
20. Gosalbes MJ, Llop S, Valles Y, et al. Meconium microbiota types dominated by lactic acid or enteric bacteria are differentially associated with maternal eczema and respiratory problems in infants. Clin Exp Allergy. 2013;43(2):198–211. doi: 10.1111/cea.12063
21. Aagaard K, Ma J, Antony KM, et al. The placenta harbors a unique microbiome. Sci Transl Med. 2014;6(237):237ra65. doi: 10.1126/scitranslmed.3008599
22. Collado MC, Rautava S, Aakko J, et al. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci Rep. 2016;6:23129. doi: 10.1038/srep23129
23. Zheng J, Xiao X, Zhang Q, et al. The Placental Microbiome Varies in Association with Low Birth Weight in Full-Term Neonates. Nutrients. 2015;7(8):6924–6937. doi: 10.3390/nu7085315
24. Perez-Muñoz ME, Arrieta MC, Ramer-Tait AE, et al. A critical assessment of the “sterile womb” and “in utero colonization” hypotheses: implications for research on the pioneer infant microbiome. Microbiome. 2017;5(1):48. doi: 10.1186/s40168-017-0268-4
25. Lauder AP, Roche AM, Sherrill-Mix S, et al. Comparison of placenta samples with contamination controls does not provide evidence for a distinct placenta microbiota. Microbiome. 2016;4(1):29. doi: 10.1186/s40168-016-0172-3
26. Rautava S. Microbial Composition of the Initial Colonization of Newborns. Nestle Nutr Inst Workshop Ser. 2017;88:11–21. doi: 10.1159/000455209
27. Del CF, Vernocchi P, Petrucca A, et al. Phylogenetic and metabolic tracking of gut microbiota during perinatal development. PLoS One. 2015;10(9):e0137347. doi: 10.1371/journal.pone.0137347
28. Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA. 2010;107(26):11971–11975. doi: 10.1073/pnas.1002601107
29. Al-Balawi M, Morsy FM. Enterococcus faecalis Is a Better Competitor Than Other Lactic Acid Bacteria in the Initial Colonization of Colon of Healthy Newborn Babies at First Week of Their Life. Front Microbiol. 2020;11:2017. doi: 10.3389/fmicb.2020.02017
30. Friedman ES, Bittinger K, Esipova TV, et al. Microbes vs. chemistry in the origin of the anaerobic gut lumen. Proc Natl Acad Sci USA. 2018;115(16):4170–4175. doi: 10.1073/pnas.1718635115
31. Bischoff SC, Boirie Y, Cederholm T, et al. Towards a multi-disciplinary approach to understand and manage obesity and related diseases. Clin Nutr. 2017;36(4):917–938. doi: 10.1016/j.clnu.2016.11.007
32. Coscia A, Bardanzellu F, Caboni E, et al. When a Neonate Is Born, So Is a Microbiota. Life (Basel). 2021;11(2):148. doi: 10.3390/life11020148
33. de Goffau MC, Lager S, Sovio U, et al. Human placenta has no microbiome but can contain potential pathogens. Nature. 2019;572(7769):329–334. doi: 10.1038/s41586-019-1451-5
34. Grönlund MM, Grześkowiak Ł, Isolauri E, et al. Influence of mother’s intestinal microbiota on gut colonization in the infant. Gut Microbes. 2011;2(4):227–233. doi: 10.4161/gmic.2.4.16799
35. Kim H, Sitarik AR, Woodcroft K, et al. Breastfeeding, Pet Exposure, and Antibiotic Use: Associations With the Gut Microbiome and Sensitization in Children. Curr Allergy Asthma Rep. 2019;19(4):22. doi: 10.1007/s11882-019-0851-9
36. Shao Y, Forster SC, Tsaliki E, et al. Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth. Nature. 2019;574(7776):117–121. doi: 10.1038/s41586-019-1560-1
37. Yang B, Chen Y, Stanton C, et al. Bifidobacterium and Lactobacillus Composition at Species Level and Gut Microbiota Diversity in Infants before 6 Weeks. Int J Mol Sci. 2019;20(13):3306. doi: 10.3390/ijms20133306
38. Nagpal R, Tsuji H, Takahashi T, et al. Ontogenesis of the Gut Microbiota Composition in Healthy, Full-Term, Vaginally Born and Breast-Fed Infants over the First 3 Years of Life: A Quantitative Bird’s-Eye View. Front Microbiol. 2017;8:1388. doi: 10.3389/fmicb.2017.01388
39. Kim G, Bae J, Kim MJ, et al. Delayed Establishment of Gut Microbiota in Infants Delivered by Cesarean Section. Front Microbiol. 2020;11:2099. doi: 10.3389/fmicb.2020.02099
40. Jakobsson HE, Abrahamsson TR, Jenmalm MC, et al. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut. 2014;63(4):559–566. doi: 10.1136/gutjnl-2012-303249
41. Sitarik AR, Havstad SL, Johnson CC, et al. Association between cesarean delivery types and obesity in preadolescence. Int J Obes (Lond). 2020;44(10):2023–2034. doi: 10.1038/s41366-020-00663-8
42. Bäckhed F, Roswall J, Peng Y, et al. Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life. Cell Host Microbe. 2015;17(6):690–703. doi: 10.1016/j.chom.2015.04.004
43. Tapiainen T, Paalanne N, Tejesvi MV, et al. Maternal influence on the fetal microbiome in a population-based study of the firstpass meconium. Pediatr Res. 2018;84(3):371–379. doi: 10.1038/pr.2018.29
44. Le Doare K, Holder B, Bassett A, et al. Mother’s Milk: A Purposeful Contribution to the Development of the Infant Microbiota and Immunity. Front Immunol. 2018;9:361. doi: 10.3389/fimmu.2018.00361
45. Lyons KE, Ryan CA, Dempsey EM, et al. Breast Milk, a Source of Beneficial Microbes and Associated Benefits for Infant Health. Nutrients. 2020;12(4):1039. doi: 10.3390/nu12041039
46. Eshaghi M, Bibalan MH, Rohani M, et al. Bifidobacterium obtained from mother’s milk and their infant stool; A comparative genotyping and antibacterial analysis. Microb Pathog. 2017;111:94–98. doi: 10.1016/j.micpath.2017.08.014
47. Khodayar-Pardo P, Mira-Pascual L, Collado MC, et al. Impact of lactation stage, gestational age and mode of delivery on breast milk microbiota. J Perinatol. 2014;34(8):599–605. doi: 10.1038/jp.2014.47
48. Moossavi S, Azad MB. Origins of human milk microbiota: New evidence and arising questions. Gut Microbes. 2020;12(1):1667722. doi: 10.1080/19490976.2019.1667722
49. Łubiech K, Twaruzek M. Lactobacillus Bacteria in Breast Milk. Nutrients. 2020;12(12):3783. doi: 10.3390/nu12123783
50. Toscano M, De Grandi R, Grossi E, et al. Role of the Human Breast Milk-Associated Microbiota on the Newborns’ Immune System: A Mini Review. Front Microbiol. 2017;8:2100. doi: 10.3748/wjg.v21.i29.8787
51. Soto A, Martín V, Jiménez E, et al. Lactobacilli and bifidobacteria in human breast milk: Influence of antibiotherapy and other host and clinical factors. J Pediatric Gastroenterol Nutr. 2014;59(1):78–88. doi: 10.1097/MPG.0000000000000347
52. Mastromarino P, Capobianco D, Miccheli A, et al. Administration of a multistrain probiotic product (VSL#3) to women in the perinatal period di_erentially a_ects breast milk beneficial microbiota in relation to mode of delivery. Pharmacol Res. 2015;95–96:63–70. doi: 10.1016/j.phrs.2015.03.013
53. Abrahamsson TR, Sinkiewicz G, Jakobsson T, et al. Probiotic lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life. J Pediatric Gastroenterol Nutr. 2009;49:349–354. doi: 10.1016/j.phrs.2015.03.013
54. Arroyo R, Martín V, Maldonado A, et al. Treatment of infectious mastitis during lactation: Antibiotics versus oral administration of lactobacilli isolated from breast milk. Clin Infect Dis. 2010;50: 1551–1558. doi: 10.1086/652763
55. Beasley SS, Saris PEJ. Nisin-producing Lactococcus lactis trains isolated from human milk. Appl Environ Microbiol. 2004;70(8): 5051–5053. doi: 10.1128/AEM.70.8.5051-5053.2004
56. Díaz-Ropero M, Martín R, Sierra S, et al. Two Lactobacillus strains, isolated from breast milk, differently modulate the immune response. J Appl Microbiol. 2007;102(2):337–343. doi: 10.1111/j.1365-2672.2006.03102.x
57. Jones KM, Power ML, Queenan JT, et al. Racial and Ethnic Disparities in Breastfeeding. Breastfeed Med. 2015;10(4): 186–196. doi: 10.1089/bfm.2014.0152
58. Azad MB, Nickel NC, Bode L, et al. Breastfeeding and the origins of health: Interdisciplinary perspectives and priorities. Matern Child Nutr. 2021;17(2):e13109. doi: 10.1111/mcn.13109
59. Решетник Л.А. Вскармливание детей первого года: учебное пособие. — Иркутск: ИГМУ; 2019. — 51 с.
60. Lönnerdal B. Infant formula and infant nutrition: bioactive proteins of human milk and implications for composition of infant formulas. Am J Clin Nutr. 2014;99(3):712S–717S. doi: 10.3945/ajcn.113.071993
61. Almeida CC, Mendonça Pereira BF, Leandro KC, et al. Bioactive Compounds in Infant Formula and Their Effects on Infant Nutrition and Health: A Systematic Literature Review. Int J Food Sci. 2021;2021:8850080. doi: 10.1155/2021/8850080
62. Smilowitz JT, O’Sullivan A, Barile D, et al. The human milk metabolome reveals diverse oligosaccharide profiles. J Nutr. 2013; 143(11):1709–1718. doi: 10.3945/jn.113.178772
63. Browne PD, Aparicio M, Alba C, et al. Human milk microbiome and maternal postnatal psychosocial distress. Front Microbiol. 2019;10:2333. doi: 10.3389/fmicb.2019.02333
64. Anjum J, Nazir S, Tariq M, et al. Lactobacillus commensals autochthonous to human milk have the hallmarks of potent probio tics. Microbiology (Reading). 2020;166(10):966–980. doi: 10.1099/mic.0.000966
65. Azagra-Boronat I, Tres A, Massot-Cladera M, et al. Rodríguez-Lagunas. Lactobacillus fermentum CECT5716 Supplementation in Rats during Pregnancy and Lactation Impacts Maternal and O_spring Lipid Profile, Immune System and Microbiota. Cells. 2020;9(3):575. doi: 10.3390/cells9030575
66. Maldonado J, Cañabate F, Sempere L, et al. Human milk probiotic Lactobacillus fermentum CECT5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants. J Pediatr Gastroenterol Nutr. 2012;54(1):55–61. doi: 10.1097/MPG.0b013e3182333f18
67. Gil-Campos M, López MÁ, Rodriguez-Benítez MV, et al. Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1–6 months of age: A randomized controlled trial. Pharmacol Res. 2012;65(2):231–238. doi: 10.1016/j.phrs.2011.11.016
68. Martín R, Langa S, Reviriego C, et al. Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr. 2003;143:754–758. doi: 10.1016/j.jpeds.2003.09.028
69. Kocabay S, Çetinkaya S. Probiotic Properties of a Lactobacillus fermentum Isolated from Newborn Faeces. J Oleo Sci. 2020; 69(12):1579–1584. doi: 10.5650/jos.ess20224
70. Maldonado-Lobón JA, Gil-Campos M, Maldonado J, et al. Long-term safety of early consumption of Lactobacillus fermentum CECT5716: A 3-year follow-up of a randomized controlled trial. Pharmacol Res. 2015;95–96:12–19. doi: 10.1016/j.phrs.2015.01.006
71. Pérez-Cano FJ, Dong H, Yaqoob P. In vitro immunomodulatory activity of Lactobacillus fermentum CECT5716 and Lactobacillus salivarius CECT5713: two probiotic strains isolated from human breast milk. Immunobiology. 2010;215(12):996–1004. doi: 10.1016/j.imbio.2010.01.004
72. Maldonado J, Gil-Campos M, Maldonado-Lobón JA, et al. Evaluation of the safety, tolerance and efficacy of 1-year consumption of infant formula supplemented with Lactobacillus fermentum CECT5716 Lc40 or Bifidobacterium breve CECT7263: a randomized controlled trial. BMC Pediatr. 2019;19(1):361. doi: 10.1186/s12887-019-1753-7
73. López-Huertas E. Safety and efficacy of human breast milk Lactobacillus fermentum CECT 5716. A mini-review of studies with infant formulae. Benef Microbes. 2015;6(2):219–224. doi: 10.3920/BM2014.0091
74. Ben XM, Li J, Feng ZT, et al. Low level of galacto-oligosaccharide in infant formula stimulates growth of intestinal Bifidobacteria and Lactobacilli. World J Gastroenterol. 2008;14(42):6564–6568. doi: 10.3748/wjg.14.6564
75. Fanaro S, Marten B, Bagna R, et al. Galacto-oligosaccharides are bifidogenic and safe at weaning: a double-blind randomized multicenter study. J Pediatr Gastroenterol Nutr. 2009;48(1):82–88. doi: 10.1097/MPG.0b013e31817b6dd2
76. Olivares M, Díaz-Ropero MP, Sierra S, et al. Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition. 2007;23(3):254–260. doi: 10.1016/j.nut.2007.01.004
77. Drover JR, Hoffman DR, Castañeda YS, et al. Cognitive function in 18-month-old term infants of the DIAMOND study: a randomized, controlled clinical trial with multiple dietary levels of docosahexaenoic acid. Early Hum Dev. 2011;87(3):223–230. doi: 10.1016/j.earlhumdev.2010.12.047
78. Mie A, Andersen HR, Gunnarsson S, et al. Human health implications of organic food and organic agriculture: a comprehensive review. Environ Health. 2017;16(1):111. doi: 10.1186/s12940-017-0315-4
79. Średnicka-Tober D, Barański M, Seal CJ, et al. Higher PUFA and n-3 PUFA, conjugated linoleic acid, α-tocopherol and iron, but lower iodine and selenium concentrations in organic milk: a systema tic literature review and meta-and redundancy analyses. Br J Nutr. 2016;115(6):1043–1060. doi: 10.1017/S0007114516000349
80. Woods VB, Fearon AM. Dietary sources of unsaturated fatty acids for animals and their transfer into meat, milk and eggs: a review. Livest Sci. 2009;126(1):1–20. doi: 10.1016/j.livsci.2009.07.002
Рецензия
Для цитирования:
Беляева И.А., Намазова-Баранова Л.С., Бомбардирова Е.П., Турти Т.В., Садчиков П.Е. Таргетное формирование микробиоты младенцев на искусственном вскармливании: современные возможности. Вопросы современной педиатрии. 2021;20(6):484-491. https://doi.org/10.15690/vsp.v20i6.2354
For citation:
Belyaeva I.A., Namazova-Baranova L.S., Bombardirova E.P., Turti T.V., Sadchikov P.E. Targeted Development of Infant Microbiota on Formula Feeding: Modern Options. Current Pediatrics. 2021;20(6):484-491. (In Russ.) https://doi.org/10.15690/vsp.v20i6.2354